Glanbia Plc ADR (OTCMKTS:GLAPY – Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 145 shares, a growth of 98.6% from the September 15th total of 73 shares. Based on an average trading volume of 46 shares, the days-to-cover ratio is presently 3.2 days. Currently, 0.0% of the company’s shares are short sold.
Glanbia Price Performance
Shares of OTCMKTS:GLAPY remained flat at $108.40 during mid-day trading on Thursday. 102 shares of the stock were exchanged, compared to its average volume of 24. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.84 and a current ratio of 1.53. Glanbia has a 52 week low of $86.47 and a 52 week high of $143.50. The firm’s fifty day simple moving average is $124.66 and its two-hundred day simple moving average is $121.67.
Glanbia Company Profile
Glanbia plc is an Ireland-based global nutrition company that develops, manufactures and markets performance, lifestyle and health-focused nutrition products. Its portfolio includes protein powders, bars, shakes, supplements and other nutritional products sold through retail, e-commerce, specialty and foodservice channels.
Through its Glanbia Performance Nutrition business, the company markets brands including Optimum Nutrition, Isopure, SlimFast and BSN. Glanbia Nutritionals supplies nutritional ingredients, premixes and solutions to food, beverage and supplement manufacturers, while its broader operations also include dairy and cheese activities serving consumer and commercial markets.
Glanbia traces its history to the Irish dairy cooperatives Avonmore and Waterford Foods, which merged in 1997 to form the company.
See Also
- Five stocks we like better than Glanbia
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.
